Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population

KT Simms, A Keane, DTN Nguyen, M Caruana… - Nature Medicine, 2023 - nature.com
Abstract In 2020, the World Health Organization (WHO) launched a strategy to eliminate
cervical cancer as a public health problem. To support the strategy, the WHO published …

Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment …

JB Lew, KT Simms, MA Smith, M Hall… - The Lancet Public …, 2017 - thelancet.com
Summary Background Australia's National Cervical Screening Program currently
recommends cytological screening every 2 years for women aged 18–69 years. Human …

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV …

K Canfell, M Caruana, V Gebski… - PLoS …, 2017 - journals.plos.org
Background Using primary human papillomavirus (HPV) testing for cervical screening
increases detection of high-grade cervical intraepithelial neoplastic lesions and invasive …

Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: example from Australia

MT Hall, KT Simms, JB Lew, MA Smith, M Saville… - PloS one, 2018 - journals.plos.org
Background Many countries are transitioning from cytology-based to longer-interval HPV
screening. Trials comparing HPV-based screening to cytology report an increase in CIN2/3 …

Comparison of HPV-16 and HPV-18 genotyping and cytological testing as triage testing within human papillomavirus–based screening in Mexico

L Torres-Ibarra, J Cuzick, AT Lorincz… - JAMA network …, 2019 - jamanetwork.com
Importance Triage tests enhance the efficiency cervical cancer screening based on human
papillomavirus (HPV), but the best approach for maximizing programmatic effectiveness is …

Hormonal contraceptive use and smoking as risk factors for high-grade cervical intraepithelial neoplasia in unvaccinated women aged 30–44 years: A case-control …

H Xu, S Egger, LS Velentzis, DL O'Connell, E Banks… - Cancer …, 2018 - Elsevier
Background Human papillomavirus (HPV) vaccines protect against HPV types 16/18, but do
not eliminate the need to detect pre-cancerous lesions. Australian women vaccinated as …

National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study

MA Smith, M Sherrah, F Sultana, PE Castle, M Arbyn… - bmj, 2022 - bmj.com
Objective To review the first two years of the primary human papillomavirus (HPV) cervical
screening programme in an HPV vaccinated population. Design Observational study …

Routine cervical screening by primary HPV testing: early findings in the renewed National Cervical Screening Program

DA Machalek, JM Roberts, SM Garland… - Medical Journal of …, 2019 - Wiley Online Library
Objectives To report human papillomavirus (HPV) testing patterns and rates of oncogenic
HPV‐positivity for specimens submitted during the first 6 months after the National Cervical …

A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia

C Nickson, MA Smith, E Feletto, LS Velentzis, K Broun… - Elife, 2023 - elifesciences.org
Australia introduced COVID-19 infection prevention and control measures in early 2020. To
help prepare health services, the Australian Government Department of Health …

[HTML][HTML] Correlates of intention-to-attend and confirmed cervical screening attendance during the COVID-19 pandemic in Australia: Findings from Compass-PLUS, a …

LS Velentzis, S Egger, J Waller, CJ Jennett… - Preventive Medicine …, 2024 - Elsevier
Objective The coronavirus pandemic impacted health-seeking behaviour and access to
primary care in Australia. We investigated factors associated with intention-to-attend and …